Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tisotumab Vedotin as Second- or Third-Line Therapy for Re... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
0
Authors
Ignace Vergote
•
Antonio González‐Martín
28 more
•
Brian Slomovitz
Published
July 3, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
New England Journal of Medicine
Topics
Cancer Oncology
Internal Medicine
Surgery
Obstetrics And Gynecology
Medicine
Cancer Oncology
Internal Medicine
Surgery
Obstetrics And Gynecology
Show all topics
DOI
10.1056/nejmoa2313811
